Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy
Mudasir Nabi Peerzada, Parvez Κhan, Nashrah Sharif Khan, et al.
ACS Omega (2020) Vol. 5, Iss. 36, pp. 22759-22771
Open Access | Times Cited: 19

Showing 19 citing articles:

Advances of antitumor drug discovery in traditional Chinese medicine and natural active products by using multi‐active components combination
Wei Zhao, Xiao‐Di Zheng, Paula Yun‐Zhi Tang, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 5, pp. 1778-1808
Closed Access | Times Cited: 34
Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development
Mudasir Nabi Peerzada, Ernest Hamel, Ruoli Bai, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107860-107860
Closed Access | Times Cited: 53
Emerging role of microtubule-associated proteins on cancer metastasis
Onsurang Wattanathamsan, Varisa Pongrakhananon
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 35
Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches
Akhtar Atiya, Debarati Das Gupta, Abdulrhman Alsayari, et al.
ACS Omega (2023) Vol. 8, Iss. 7, pp. 6423-6430
Open Access | Times Cited: 12
Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII Inhibitors
Mudasir Nabi Peerzada, Daniela Vullo, Niccolò Paoletti, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 810-819
Open Access | Times Cited: 10
A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma
Sarfraz Ahmed, Mohammad Mobashir, Lamya Ahmed Al‐Keridis, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases
Manzar Alam, Sarfraz Ahmed, Mohammad Abid, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 9, pp. 1223-1240
Open Access | Times Cited: 9
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 7
Integrated analysis of potential pathways by which aloe-emodin induces the apoptosis of colon cancer cells
Dongxiao Jiang, Shufei Ding, Zhu-Jun Mao, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Emerging role of protein kinases in diabetes mellitus: From mechanism to therapy
Preeti Gupta, Aaliya Taiyab, Md. Imtaiyaz Hassan
Advances in protein chemistry and structural biology (2020), pp. 47-85
Closed Access | Times Cited: 11
Chemoinformatic Design and Profiling of Derivatives of Dasabuvir, Efavirenz, and Tipranavir as Potential Inhibitors of Zika Virus RNA-Dependent RNA Polymerase and Methyltransferase
Madeleine I. Ezeh, Onyinyechi E. Okonkwo, Innocent N. Okpoli, et al.
ACS Omega (2022) Vol. 7, Iss. 37, pp. 33330-33348
Open Access | Times Cited: 6
Multitargeting the Action of 5-HT6 Serotonin Receptor Ligands by Additional Modulation of Kinases in the Search for a New Therapy for Alzheimer’s Disease: Can It Work from a Molecular Point of View?
Kinga Czarnota-Łydka, Katarzyna Kucwaj‐Brysz, Patryk Pyka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8768-8768
Open Access | Times Cited: 5
Using 5-Nitroimidazole Derivatives against Neglected Tropical Protozoan Diseases: Systematic Review
Micheel Merari Vichi-Ramírez, Edgar López‐López, Catalina Soriano‐Correa, et al.
Future Pharmacology (2024) Vol. 4, Iss. 1, pp. 222-255
Open Access
Naturbasierte bioinformatische Ansätze in der Arzneimittelforschung gegen vielversprechende molekulare Ziele – Carbonanhydrasen und Serin/Threonin-Kinasen zur Krebsbehandlung
Mudasir Nabi Peerzada, Masood Ahmad Rizvi, K.K. Ajeeshkumar, et al.
(2024), pp. 343-363
Closed Access
MARK4 promotes the malignant phenotype of gastric cancer through the MAPK/ERK signaling pathway
Fubin Ma, Jibin Yao, Xingdong Niu, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155471-155471
Closed Access
Privileged Scaffolds in Drug Discovery against Human Epidermal Growth Factor Receptor 2 for Cancer Treatment
Mudasir Nabi Peerzada, Rania Hamdy, Masood Ahmad Rizvi, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 44, pp. 3563-3578
Closed Access | Times Cited: 1
Nature-Based Computing Bioinformatics Approaches in Drug Discovery Against Promising Molecular Targets Carbonic Anhydrases and Serine/Threonine Kinases for Cancer Treatment
Mudasir Nabi Peerzada, Masood Ahmad Rizvi, Ajeesh Kumar KK, et al.
Studies in computational intelligence (2022), pp. 309-328
Closed Access | Times Cited: 2
The Mechanism of Aloe-emodin in the Treatment of Colon Cancer based on Network Pharmacological Analysis
Dongxiao Jiang, Shufei Ding, Zhu-Jun Mao, et al.
Research Square (Research Square) (2020)
Open Access | Times Cited: 1
Discovery of medicinal herbal compounds with potential anti-cancer activities against microtubule affinity-regulating kinase (MARK4) in cancer therapy
Nayana Narayanan, Sivakumar Krishnankutty Chandrika
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top